How subtle differences in polymer molecular weight affect doxorubicin-loaded PLGA nanoparticles degradation and drug release

References

• Alexis, F., 2005. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]. Polymer international, 54 (1), 36–46.
   Web of Science ®Google Scholar
• Allison, S.D., 2008. Analysis of initial burst in PLGA microparticles. Expert opinion on drug delivery, 5 (6), 615–628.
   PubMed Web of Science ®Google Scholar
• Araújo, J., et al., 2009. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-laded PLGA nanospheres. Colloids and surfaces B: biointerfaces, 72 (1), 48–56.
   PubMed Web of Science ®Google Scholar
• Basavaraj, S., and Betageri, G.V., 2014. Can formulation and drug delivery reduce attrition during drug discovery and development – review of feasibility, benefits and challenges. Acta pharmaceutica sinica b, 4 (1), 3–17.
   PubMed Web of Science ®Google Scholar
• Birnbaum, D.T., and Brannon-Peppas, L., 2003. Molecular weight distribution changes during degradation and release of PLGA nanoparticles containing epirubicin HCl. Journal of biomaterials science, polymer edition, 14 (1), 87–102.
   PubMed Web of Science ®Google Scholar
• Bobo, D., et al., 2016. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharmaceutical research, 33 (10), 2373–2387.
   PubMed Web of Science ®Google Scholar
• Danhier, F., et al., 2012. PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release, 161 (2), 505–522.
   PubMed Web of Science ®Google Scholar
• Engineer, C., Parikh, J., and Raval, A., 2011a. Review on hydrolytic degradation behavior of biodegradable polymers from controlled drug delivery system. Trends in biomaterials and artificial organs, 25 (2), 79–85.
   Google Scholar
• Engineer, C., Parikh, J., and Raval, A., 2011b. Effect of copolymer ratio on hydrolytic degradation of poly(lactide-co-glycolide) from drug eluting coronary stents. Chemical engineering research and design, 89 (3), 328–334.
   Web of Science ®Google Scholar
• Feng, S., et al., 2015. Effects of drug and polymer molecular weight on drug release from PLGA‐mPEG microspheres. Journal of applied polymer science, 132 (6), 41431.
   Web of Science ®Google Scholar
• Fredenberg, S., et al., 2011. The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems – a review. International journal of pharmaceutics, 415 (1–2), 34–52.
   PubMed Web of Science ®Google Scholar
• Gaspar, M.M., et al., 1998. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. Journal of controlled release, 52 (1–2), 53–62.
   PubMed Web of Science ®Google Scholar
• Giunchedi, P., et al., 1998. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination. Journal of controlled release, 56 (1–3), 53–62.
   PubMed Web of Science ®Google Scholar
• Grayson, A.C., et al., 2004. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip. Journal of biomaterials science, polymer edition, 15 (10), 1281–1304.
   PubMed Web of Science ®Google Scholar
• Hines, D.J., and Kaplan, D.L., 2013. Poly (lactic-co-glycolic acid) controlled release systems: experimental and modeling insights. Critical reviews in therapeutic drug carrier systems, 30 (3), 257–276.
   PubMed Web of Science ®Google Scholar
• Hua, S., et al., 2018. Current Trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Frontiers in pharmacology, 9, 790.
   PubMed Web of Science ®Google Scholar
• Hussein, A.S., Ahmadun, F.-R., and Abdullah, N., 2013. In vitro degradation of poly (d, l-lactide-co-glycolide) nanoparticles loaded with linamarin. IET nanobiotechnology, 7 (2), 33–41.
   PubMed Web of Science ®Google Scholar
• Hyon, S.H., Jamshidi, K., and Ikada, Y., 1998. Effects of residual monomer on the degradation of dl‐lactide polymer. Polymer international, 46 (3), 196–202.
   Web of Science ®Google Scholar
• Jahan, S.T., and Haddadi, A., 2015. Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles. International journal of nanomedicine, 10, 7371–7384.
   PubMed Web of Science ®Google Scholar
• Kenley, R.A., et al., 1987. Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro. Macromolecules, 20 (10), 2398–2403.
   Web of Science ®Google Scholar
• Körber, M., 2010. PLGA erosion: solubility- or diffusion-controlled? Pharmaceutical research, 27 (11), 2414–2420.
   PubMed Web of Science ®Google Scholar
• Maksimenko, O., et al., Gelperina, S., 2019. Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development. International journal of pharmaceutics, 572, 118733.
   PubMed Web of Science ®Google Scholar
• Malinovskaya, Y., et al., Kreuter, J., 2017. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. International journal of pharmaceutics, 524 (1–2), 77–90.
   PubMed Web of Science ®Google Scholar
• Mittal, G., et al., 2007. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. Journal of controlled release, 119 (1), 77–85.
   PubMed Web of Science ®Google Scholar
• Naha, P.C., Byrne, H.J., and Panda, A.K., 2013. Role of polymeric excipients on controlled release profile of glipizide from PLGA and Eudragit RS 100 nanoparticles. Journal of nanopharmaceutics and drug delivery, 1 (1), 74–81.
   Google Scholar
• Panyam, J., et al., Labhasetwar, V., 2003. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. Journal of controlled release, 92 (1–2), 173–187.
   PubMed Web of Science ®Google Scholar
• Park, T.G., 1995. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials, 16 (15), 1123–1130.
   PubMed Web of Science ®Google Scholar
• Pereverzeva, E., et al., Gelperina, S., 2019. Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma. International journal of pharmaceutics, 554, 161–178.
   PubMed Web of Science ®Google Scholar
• Rezvantalab, S., et al., Kiessling, F., 2018. PLGA-based nanoparticles in cancer treatment. Frontiers in pharmacology, 9, 1260.
   PubMed Web of Science ®Google Scholar
• Sharman, D., 1997. Determination of lactic acid and poly(lactic acid)s in a dermatological formulation by capillary electrophoresis. The analyst, 122 (7), 709–713.
   PubMed Web of Science ®Google Scholar
• Shi, J., et al., 2017. Cancer nanomedicine: progress, challenges and opportunities. Nature reviews cancer, 17 (1), 20–37.
   PubMed Web of Science ®Google Scholar
• Toshiro, H., et al., 1991. Factors influencing the profiles of TRH release from copoly(d,l-lactic/glycolic acid) microspheres. International journal of pharmaceutics, 72 (3), 199–205.
   Web of Science ®Google Scholar
• Tracy, M.A., et al., 1999. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials, 20 (11), 1057–1062.
   PubMed Web of Science ®Google Scholar
• Wu, X.S., and Wang, N., 2001. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation. Journal of biomaterials science, polymer edition, 12 (1), 21–34.
   PubMed Web of Science ®Google Scholar
• Xu, Y., et al., 2017. Polymer degradation and drug delivery in PLGA-based drug–polymer applications: a review of experiments and theories. Journal of biomedical materials research part B: applied biomaterials, 105 (6), 1692–1716.
   PubMed Web of Science ®Google Scholar
• Zhu, G., and Schwendeman, S.P., 2000. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharmaceutical research, 17 (3), 351–357.
   PubMed Web of Science ®Google Scholar